×
Please click
here
if you are not redirected within a few seconds.
All
News
Images
Videos
Maps
Shopping
Books
Search tools
Recent
Recent
Past hour
Past 24 hours
Past week
Past month
Past year
Archives
Sorted by relevance
Sorted by relevance
Sorted by date
Sonnet BioTherapeutics Announces a Publication Demonstrating Safety and Tolerability of SON-1010 in Healthy ...
Yahoo Finance
PRINCETON, NJ / ACCESSWIRE / February 29, 2024 / Sonnet BioTherapeutics Holdings, Inc., (NASDAQ:SONN) a clinical-stage company developing...
2 months ago
Sonnet BioTherapeutics to Present Preclinical Data on SON-080 for Chemotherapy-Induced Peripheral Neuropathy ...
Kansas City Star
Sonnet BioTherapeutics Holdings, Inc. (NASDAQ:SONN) ("Sonnet" or the "Company"), a biopharmaceutical company developing innovative targeted...
1 month ago
Sonnet BioTherapeutics Regains Compliance, Risks Nasdaq Delisting - TipRanks.com
Tipranks
Sonnet BioTherapeutics Holdings (SONN) has released an update. The Company was notified by Nasdaq on December 15, 2023, of non-compliance...
2 months ago
Why Is Sonnet BioTherapeutics (SONN) Stock Down 33% Today?
InvestorPlace
Sonnet BioTherapeutics stock is dropping on Wednesday after the company revealed the pricing of a public offering for SONN shares.
6 months ago
Sonnet BioTherapeutics Holdings First Quarter 2024 Earnings: Beats Expectations
Yahoo Finance
Sonnet BioTherapeutics Holdings ( NASDAQ:SONN ) First Quarter 2024 Results Key Financial Results Net loss: US$1.17m...
2 months ago
Founder of Sonnet BioTherapeutics Holdings Picks Up 149% More Stock \
Simply Wall Street
Founder of Sonnet BioTherapeutics Holdings Picks Up 149% More Stock \ ... Even if it's not a huge purchase, we think it was good to see that...
11 months ago
Sonnet BioTherapeutics Advances SON-080 into Phase 2 Trials - TipRanks.com
Tipranks
The latest update is out from Sonnet BioTherapeutics Holdings (SONN). The Company's groundbreaking treatment for chemotherapy-induced...
1 month ago
Why Is Sonnet BioTherapeutics (SONN) Stock Down 5% Today?
InvestorPlace
Sonnet BioTherapeutics (SONN) stock is taking a beating on Monday after the company announced details for a public stock offering.
8 months ago
Sonnet BioTherapeutics Provides Fiscal Year 2024 First Quarter Business and Earnings Update
Yahoo Finance
On January 24, 2024, the Company executed an agreement pursuant to the program whereby a buyer has agreed to purchase, and the Company agreed to...
2 months ago
J&J-partnered Sonnet halts work on bispecific while hunting for fresh collaborators
Fierce Biotech
In these financially straitened times, biotechs need to be increasingly ruthless about which programs they can afford to keep funding.
16 months ago